Dr. Jukka-Pekka Mecklin

Claim this profile

Tampere University Hospital and Tampere University

Studies Transitional Cell Carcinoma
Studies Cancer Syndromes
1 reported clinical trial
2 drugs studied

Area of expertise

1

Transitional Cell Carcinoma

Jukka-Pekka Mecklin has run 1 trial for Transitional Cell Carcinoma. Some of their research focus areas include:

MLH1 positive
MSH2 positive
MSH6 positive
2

Cancer Syndromes

Jukka-Pekka Mecklin has run 1 trial for Cancer Syndromes. Some of their research focus areas include:

MLH1 positive
MSH2 positive
MSH6 positive

Clinical Trials Jukka-Pekka Mecklin is currently running

More about Jukka-Pekka Mecklin

Clinical Trial Related

2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial

Treatments Jukka-Pekka Mecklin has experience with

  • Urothelial Cancer Screening Using Urine Cytology
  • Urothelial Cancer Screening Using Urine Tumor DNA Test

Breakdown of trials Jukka-Pekka Mecklin has run

Transitional Cell Carcinoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Jukka-Pekka Mecklin specialize in?

Is Jukka-Pekka Mecklin currently recruiting for clinical trials?

Are there any treatments that Jukka-Pekka Mecklin has studied deeply?

What is the best way to schedule an appointment with Jukka-Pekka Mecklin?

Is there any support for travel costs?